References
- World Health Organisation. WHO Coronavirus (COVID-19) dashboard. Geneva. 2021 Sep 12 [accessed 2021 Sep 13]. https://covid19.who.int/ .
- World Health Organisation. COVID-19 vaccine tracker and landscape. Geneva. 2021 Sep 7 [accessed 2021 Sep 13]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines .
- Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–10. doi:10.1016/S0140-6736(21)00947-8 .
- Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, Wellington E, Stowe J, Gillson N, Atti A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725–35. doi:10.1016/S0140-6736(21)00790-X .
- Vasileiou E, Simpson CR, Shi T, Kerr S, Agrawal U, Akbari A, Bedston S, Beggs J, Bradley D, Chuter A, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397(10285):1646–57. doi:10.1016/S0140-6736(21)00677-2 .
- Abu-Raddad LJ, Chemaitelly H, Butt AA, National Study Group for COVID-19 Vaccination. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J Med. 2021;385(2):187–89. doi:10.1056/NEJMc2104974 .
- Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O’Doherty M, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088 .
- Nasreen S, He S, Chung H, Brown K, Gubbay JB, Buchan SA, Wilson SE, Sundaram ME, Fell DB, and Chen B, et al. Effectiveness of COVID-19 vaccines against variants of concern, Canada. medRxiv Prepr 2021. doi:10.1101/2021.06.28.21259420 .
- Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier R, Groves N, Dabera G, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021;385(7):585–94. doi:10.1056/NEJMoa2108891 .
- Sheikh A, McMenamin J, Taylor B, Robertson C. Public Health Scotland and the EAVE II Collaborators. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461–62. doi:10.1016/S0140-6736(21)01358-1 .
- Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021;397(10282):1351–62. doi:10.1016/S0140-6736(21)00628-0 .
- Public Health England. COVID-19 – SARS-CoV-2: the green book chapter 14a. London. 2021 [accessed 2021 Sep 13]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/978508/Green_book_chapter_16April2021.pdf .
- Public Health Wales. Rapid COVID-19 surveillance. Cardiff. 2021 Sep 12 [accessed 2021 Sep 13]. https://public.tableau.com/profile/public.health.wales.health.protection#!/vizhome/RapidCOVID-19virology-Public .
- Jones KH, Ford DV, Thompson S, Lyons RA. A profile of the SAIL databank on the UK secure research platform. Int J Popul Data Sci. 2019;4(2):1134. doi:10.23889/ijpds.v4i2.1134 .
- Lyons RA, Jones KH, John G, Brooks CJ, Verplancke JP, Ford DV, Brown G, Leake K. The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak. 2009;9:3. doi:10.1186/1472-6947-9-3 .
- Ford DV, Jones KH, Verplancke JP, Lyons RA, John G, Brown G, Brooks CJ, Thompson S, Bodger O, Couch T, et al. The SAIL databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res. 2009;9:157. doi:10.1186/1472-6963-9-157 .
- Lyons J, Akbari A, Torabi F, Davies GI, North L, Griffiths R, Bailey R, Hollinghusrt J, Fry R, Turner SL, et al. Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventions. BMJ Open. 2020;10(10):e043010. doi:10.1136/bmjopen-2020-043010 .
- Office for National Statistics. Coronavirus (COVID-19) infection survey: characteristics of people testing positive for COVID-19 in England, 22 February 2021. Newport 2021 Feb 22 [accessed 2021 Nov 11]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/characteristicsofpeopletestingpositiveforcovid19inengland
- National Health Service. Who is at high risk from coronavirus (clinically extremely vulnerable). London. 2021 Sep 2 [accessed 2021 Sep 13]. https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/who-is-at-high-risk-from-coronavirus-clinically-extremely-vulnerable .
- Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731. doi:10.1136/bmj.m3731 .
- Olmos A, Govindasamy, and Priyalatha P. A practical guide for using propensity score weighting in R. Pract Assess Res Eval. 2015;20(13).http://www.math.umd.edu/~slud/s818M-MissingData/PropensityScoreWeightingR.pdf
- Welsh Government. Welsh index of multiple deprivation 2019. Cardiff. 2020 Oct 1 [accessed 2021 Sep 13]. http://gov.wales/statistics-and-research/welsh-index-multiple-deprivation/?lang=en .
- Office for National Statistics. 2011 rural/urban classification. Newport. 2016 Jan 27 [accessed 2021 Sep 13]. https://www.ons.gov.uk/methodology/geography/geographicalproducts/ruralurbanclassifications/2011ruralurbanclassification .
- Nafilyan V, Humberstone B, Mehta N, Diamond I, Coupland C, Lorenzi L, Pawelek P, Schofield R, Morgan J, Brown P, et al. An external validation of THE QCovid risk prediction algorithm for risk of mortality FROM COVID-19 in adults: a NATIONAL Validation cohort study in England. Lancet Digital Health. 2021;3(7):e425–e433. doi:10.1016/S2589-7500(21)00080-7 .
- Government Statistical Service. Harmonised concepts and questions for social data sources: ethnic group. Newport UK: Office for National Statistics; 2015 [accessed 2021 Sep 13]. https://gss.civilservice.gov.uk/wp-content/uploads/2016/03/P3-Ethnic-Group-June-16-1.pdf .
- Welsh Parliament. Coronavirus timeline: welsh and UK governments’ response. Cardiff. 2021 May 27 [accessed 2021 Sep 13]. https://research.senedd.wales/research-articles/coronavirus-timeline-welsh-and-uk-governments-response/ .
- Thomas SJ, Moreira JED, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, and Zerbini C, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine. medRxiv Prepr 2021. doi:10.1101/2021.07.28.21261159 .
- Lee J, Little TD. A practical guide to propensity score analysis for applied clinical research. Behav Res Ther. 2017;98:76–90. doi:10.1016/j.brat.2017.01.005 .
- Lanza ST, Moore JE, Butera NM. Drawing causal inferences using propensity scores: a practical guide for community psychologists. Am J Community Psychol. 2013;52(3–4):380–92. doi:10.1007/s10464-013-9604-4 .
- Potter FJ. The effect of weight trimming on nonlinear survey estimates. Proceedings of the Section on Survey Research Methods of American Statistical Association; San Francisco, CA: American Statistical Association; 1993 .